NASDAQ · Medical - Instruments & Supplies

ATRC (ATRC) Stock

$38.72 +2.54% NASDAQ: ATRC Healthcare

Valuation

MetricValue
Price$38.72
Market Cap$1.97B
P/E Ratio80.24
P/B Ratio2.88
P/S Ratio2.57
EPS (TTM)$0.40
52-Week High$43.18
52-Week Low$25.36
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-0.97%
ROA-0.30%
ROCE-0.61%
Gross Margin75.47%
Operating Margin-0.36%
Net Margin-0.83%
Debt/Equity0.15
Current Ratio3.94

Annual Financials (USD)

Metric20212022202320242025
Revenue$274.0M$330.0M$399.0M$465.0M$535.0M
Operating Profit$55.0M$-43.0M$-27.0M$-40.0M$-3.0M
Net Profit$50.0M$-46.0M$-30.0M$-45.0M$-11.0M
EPS$1.09$-1.02$-0.66$-0.95$-0.24
Op Margin20.1%-12.9%-6.7%-8.6%-0.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$615.0M$585.0M$614.0M$609.0M$654.0M
Total Liabilities$132.0M$129.0M$148.0M$148.0M$162.0M
Cash$44.0M$58.0M$84.0M$123.0M$167.0M
Borrowings$76.0M$75.0M$74.0M$77.0M$88.0M

Latest News

AtriCure to Announce Second Quarter 2026 Financial Results Business Wire · Jul 2, 2026 Edwards wins FDA clearance for LAA clip, setting up competition with AtriCure and Medtronic MedTech Dive · Jun 29, 2026 AtriCure (ATRC) Soars 6.2%: Is Further Upside Left in the Stock? Zacks · Jun 19, 2026 Do Options Traders Know Something About AtriCure Stock We Don't? Zacks · Jun 11, 2026 A Look At AtriCure (ATRC) Valuation As BoxX NoAF Trial Acceleration Draws Investor Attention Simply Wall St. · Jun 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-14.0M$-22.0M$4.0M$12.0M$57.0M
Investing Cash Flow$14.0M$27.0M$-20.0M$-5.0M$-24.0M
Financing Cash Flow$-7.0M$-6.0M$1.0M$-2.0M$-5.0M
Net Cash Flow$2.0M$14.0M$26.0M$38.0M$45.0M
Free Cash Flow$-24.0M$-39.0M$-38.0M$-11.0M$48.0M

Valuation & Return Ratios

MetricValue
PEG Ratio10.00
EV / EBITDA78.11
FCF Yield3.79%
Quick Ratio3.18
Interest Coverage-0.50
Return 1Y8.08%
Return 3Y-37.55%
Return 5Y-58.45%

Ownership

Insiders Held3.86%
Institutions Held102.21%
Institutions Float Held106.31%
Institutional HolderSharesReport Date
Blackrock Inc.4,042,6812026-03-31
Wellington Management Group, LLP3,382,5552026-03-31
Alliancebernstein L.P.3,258,8722026-03-31
Hood River Capital Management LLC3,117,5452026-03-31
Vanguard Portfolio Management LLC2,702,6322026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AZTA $29.88 +6.22% -15.22 $1.38B 0.00%
BLFS $32.15 +2.78% -96.00 $1.57B 0.00%
IMCRImmunocore Holdings plc $31.95 -3.42% -85.34 $1.62B 0.00%
KMTS $23.99 +5.08% -3.85 $1.41B 0.00%
LMAT $79.00 -25.32% 35.74 $1.81B 0.87%

About ATRC

ATRC is led by CEO Michael H. Carrel, employs 1,300 people, headquartered in US, publicly traded since 2005.

ATRC stock trades at $38.72 with a market capitalization of $1.97B. The stock is valued at a price-to-earnings (P/E) ratio of 80.24, price-to-book of 2.88, price-to-sales of 2.57. Over the past 52 weeks the stock has ranged between $25.36 and $43.18, and currently trades 10.3% below its 52-week high.

On profitability, ATRC generates a return on equity (ROE) of -0.97%, return on capital employed of -0.61%, an operating margin of -0.36%, a net profit margin of -0.83%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides